Registered entities
Annexin Pharmaceuticals Ab
Reg. No. 556960-9539Sweden
Innovation
28 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 1,124 times.
| Year | Filings |
|---|---|
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 11 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 1 |
Social engagement
Social engagement: 1.4K social following, 8 posts in the last 12 months — top quartile of its industry.
Recent activity
4 Feb 2026
Partnership
ANXV in ophthalmology